Residents receiving OT/PT were not informed of daily therapy schedules. A cognitively intact resident with multiple chronic conditions and a surgical wound said therapy arrived at unscheduled times, disrupting showers, wound care, family visits, and personal plans, and sometimes leaving meals cold. Other residents in a council meeting reported the same issue, and the DOT confirmed therapy did not set resident schedules unless requested.
Missing Consent for Psychotropic Medication: A resident with dementia, anxiety, and bipolar disorder, and with severe cognitive impairment, was ordered Olanzapine for bedtime use. The record contained no signed consent from the resident or representative and no progress note showing the responsible party was notified after the risks and benefits were explained, which the DON verified.
Failure to Provide Education and Informed Consent for Psychotropic Medications: The facility did not document that residents receiving psychotropic meds were educated on the risks and benefits before treatment. Residents with diagnoses including depression, dementia, anxiety, schizoaffective disorder, PTSD, and insomnia were ordered meds such as Zoloft, Remeron, Ativan, risperidone, clonazepam, alprazolam, and quetiapine, but the record lacked evidence of informed consent. The DON confirmed the facility had no evidence of this education or consent process for these residents.
The facility failed to ensure residents receiving psychotropic meds were educated on the risks and benefits and failed to obtain informed consent before use. Four residents with diagnoses including dementia, anxiety, and depression had current orders for antipsychotic or antidepressant meds such as risperidone, venlafaxine, mirtazapine, trazodone, and sertraline, but the DON confirmed there was no documentation that the residents or their representatives were informed of the meds’ risks and side effects before administration.
Incomplete consent for psychotropic medications: The facility failed to ensure informed consent and education were completed for psychotropic use for three residents. Records showed residents receiving antianxiety, antidepressant, and antipsychotic medications for conditions such as anxiety, depression, schizophrenia, and bipolar disorder, but the psychoactive medication authorization forms did not identify the medications or related diagnoses, and one form also lacked listed side effects and a named verbal consent source. The DON confirmed the consent forms were incomplete.
Failure to Obtain Informed Consent for Psychotropic Medication: A resident with dementia, depression, and anxiety was prescribed multiple psychotropic medications, including an antidepressant, but the record lacked documented informed consent from the legal guardian for the new antidepressant before it was started. The DON confirmed there was no evidence consent had been obtained, despite facility policy requiring discussion of the medication’s risks, benefits, alternatives, and right to refuse before initiation.
A resident with schizophrenia, depression, type 2 DM, and a court-appointed guardian had a new physician order allowing LOA transcribed by an LPN, but the guardian was not notified when the order was written. The LPN confirmed the omission, RN confirmed guardians should be notified of new orders, and the DON stated the guardian was notified, while the facility had no documentation of prior guardian permission for the resident to leave the facility.
A resident who was cognitively intact and receiving Citalopram, Xanax, and Buspirone was not fully informed of the risks and benefits of his psychotropic medications. The psych NP documented education on side effects and drug interactions, but there was no documentation that risks and benefits were reviewed, and the resident stated this discussion had not occurred. The DON also verified there was no order or care plan for non-pharmacological interventions.
Failure to obtain informed consent for psychotropic medications for two residents. Both residents had intact cognition per MDS and were prescribed antidepressant, anti-anxiety, and sleep-related psychotropic medications, but their records lacked documentation of education, risks, benefits, and side effects before administration. The DON later stated the residents were educated and given copies of the consent, but the deficiency was based on the absence of consent documentation in the medical record.
A resident with dementia and severe cognitive impairment was given psychotropic medications including Xanax, Zoloft, Depakote, Remeron, and Trazodone, but the record showed no evidence that the resident’s representative was notified of or assisted with consent. The original consent was completed despite the resident’s impaired cognition, and it was not updated when additional psychotropic medications were added; the DON confirmed the consent issue and was unsure whether the son had been notified.
Self-audit
Pick a level of detail and, optionally, what to focus on — then generate a survey-ready checklist distilled from the most recent citations.
Beta · AI-generated — for reference only, not professional advice. Verify against current CMS guidance before relying on it. Assisto accepts no responsibility for how this checklist is used.
Citations used to create this checklist
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.